, 2012 W pracy opisano budowę i działanie akarbozy, jak i jej wpływ na glikemię poposiłkową. Akarboza jest ważnym lekiem hamującym powstanie jawnej cukrzycy i zmniejszającym ryzyko sercowo-naczyniowe u osób ze stanem przedcukrzycowym.
Sieradzki, Jacek
core
, 2013 Abdul R Shihabi,1 Essam M Moussa,2 Hania Sobierajska,3 Birgit Schmidt4 1Al Ain Centre, Dubai, United Arab Emirates; 2New Jeddah Hospital, Jeddah, Saudi Arabia; 3Etihad Airways Medical Centre, Abu Dhabi, United Arab Emirates; 4Bayer Schering Pharma AG ...
Sobierajska H +3 more
core
Optimization of culture medium for the cultivation of Actinoplanes sp. mutant strains and purification of acarbose: Research article [PDF]
, 2017 In order to improve the production of acarbose, the fermentation medium of acarbose-producing strain Actinoplanes sp. KCTC 9161 – L14 mutant was optimized in this internship. Fractional factorial design was employ to investigate the influences of glucose,
Le, Thanh Hoang +2 more
core +1 more source
Base case results for dapagliflozin arm versus acarbose arm.
, 2016 Base case results for dapagliflozin arm versus acarbose arm.
Hengjin Dong (398458) +5 more
core +1 more source
Effect of Betulinic Acid on Diabetes and its Associated Complications: An Experimental Study [PDF]
Journal of Clinical and Diagnostic ResearchIntroduction: Diabetes Mellitus (DM) is a metabolic disease characterised by elevated blood sugar levels and associated complications, such as inflammation, oxidative stress and tissue damage.
Sree Thalir Anbuchezian +2 more
doaj +1 more source
Acarbose impairs gut Bacteroides growth by targeting intracellular glucosidases
mBioAcarbose is a type 2 diabetes medicine that prevents dietary starch breakdown into glucose by inhibiting host amylase and glucosidase enzymes. Numerous gut species in the Bacteroides genus enzymatically break down starch and change in relative abundance ...
Haley A. Brown +6 more
doaj +1 more source
Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes
, 2023 Aims: The alpha-glucosidase inhibitor acarbose is an antidiabetic drug delaying assimilation of carbohydrates and, thus, increasing the amount of carbohydrates in the distal parts of the intestines, which in turn increases circulating levels of the gut ...
Hartmann, Bolette +19 more
core +1 more source
Effect of Acarbose on Control of Metabolic Parameters in Patients with Diabetes Type 1
پزشکی بالینی ابن سینا, 2012 Introduction & Objective: Acarbose is an intestinal alpha-glucosidase inhibitor that delays absorption of carbohydrates. Findings of some studies show that it has been effective in better control of blood glucose in patients with diabetes type 1.
Amir Ziaee +4 more
doaj
Acarbose: A New Option in the Treatment of Ulcerative Colitis by Increasing Hydrogen Production [PDF]
, 2012 Acarbose，which is clinically widely used to treat Type 2 Diabetes，is thought to act at the small intestine by competitively inhibiting enzymes that delay the release of glucose from complex carbohydrates, thereby specifically reducing post ...
Zhang, De-Qing +5 more
core +1 more source
Molecular insights of acarbose metabolization catalyzed by acarbose-preferred glucosidase
The clinical efficacy of the antidiabetic drug acarbose is hampered by degradation by the acarbose-preferred glucosidase (Apg) from K. grimontii TD1.
Jiwen Zhang +6 more
core +1 more source